Diabetes mellitus, a chronic metabolic disorder characterized by elevated blood glucose levels, presents a significant global health challenge. In recent years, the discovery of novel therapeutic agents has revolutionized diabetes management. Among these innovative approaches, GLP-1 receptor agonists have emerged as a particularly promising class o